SAM
Simplify Asset Management Portfolio holdings
AUM
$1.65B
This Quarter Return
-1.58%
1 Year Return
+8.73%
3 Year Return
+37.73%
5 Year Return
–
10 Year Return
–
AUM
$2.14B
AUM Growth
+$2.14B
(+49%)
Cap. Flow
+$729M
Cap. Flow
% of AUM
34.01%
Top 10 Holdings %
Top 10 Hldgs %
90.45%
Holding
108
New
16
Increased
40
Reduced
26
Closed
13
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$488M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$121M |
| 3 |
Simplify Multi-QIS Alternative ETF
QIS
|
$90M |
| 4 |
Simplify US Equity PLUS Upside Convexity ETF
SPUC
|
$89.1M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
$71.9M |
Top Sells
| 1 |
Simplify Stable Income ETF
BUCK
|
$109M |
| 2 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
$25.3M |
| 3 |
DexCom
DXCM
|
$5.91M |
| 4 |
Edwards Lifesciences
EW
|
$5.14M |
| 5 |
Akero Therapeutics
AKRO
|
$4.82M |
Sector Composition
| 1 | Healthcare | 7.09% |
| 2 | Energy | 1.27% |
| 3 | Real Estate | 0.5% |
| 4 | Industrials | 0.18% |
| 5 | Consumer Discretionary | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Teleflex
TFX
$5.59B
| $1.77M | 0.07% |
12,826
+84
| +0.7% | +$11.6K |
|
52
Regeneron Pharmaceuticals
REGN
$61.5B
| $1.75M | 0.07% |
2,758
-3,500
| -56% | -$2.22M |
|
53
Revvity
RVTY
$10.5B
| $1.69M | 0.06% |
16,003
+83
| +0.5% | +$8.78K |
|
54
Insmed
INSM
$28.8B
| $1.57M | 0.06% |
20,630
+110
| +0.5% | +$8.39K |
|
55
Delcath Systems
DCTH
$385M
| $1.49M | 0.06% |
117,000
+100,000
| +588% | +$1.27M |
|
56
TScan Therapeutics
TCRX
$102M
| $1.44M | 0.05% |
1,046,916
| – | – |
|
57
Abbott
ABT
$231B
| $1.44M | 0.05% |
10,858
-11,221
| -51% | -$1.49M |
|
|
WUSA
58
DELISTED
Simplify Wolfe US Equity 150/50 ETF
WUSA
| $1.36M | 0.05% |
57,200
-2,600
| -4% | -$62K |
|
|
59
DexCom
DXCM
$29.5B
| $1.28M | 0.05% |
18,809
-86,596
| -82% | -$5.91M |
|
|
PMT
60
PennyMac Mortgage Investment
PMT
$1.07B
| $1.26M | 0.05% |
86,100
+28,500
| +49% | +$418K |
|
61
Benitec Biopharma
BNTC
$348M
| $998K | 0.04% |
76,735
+398
| +0.5% | +$5.18K |
|
62
argenx
ARGX
$43.6B
| $958K | 0.04% |
1,619
+8
| +0.5% | +$4.74K |
|
|
CIM
63
Chimera Investment
CIM
$1.15B
| $907K | 0.03% |
70,700
+45,000
| +175% | +$577K |
|
64
Zevra Therapeutics
ZVRA
$509M
| $899K | 0.03% |
120,000
| – | – |
|
|
SPQ
65
DELISTED
Simplify US Equity PLUS QIS ETF
SPQ
| $795K | 0.03% |
32,131
-1,461
| -4% | -$36.1K |
|
66
Simplify Next Intangible Core Index ETF
NXTI
$27.4M
| $714K | 0.03% |
25,825
-1,174
| -4% | -$32.5K |
|
|
67
Edwards Lifesciences
EW
$47.8B
| $710K | 0.03% |
9,799
-70,959
| -88% | -$5.14M |
|
68
Ligand Pharmaceuticals
LGND
$3.15B
| $696K | 0.03% |
+6,616
| New | +$696K |
|
69
Milestone Pharmaceuticals
MIST
$156M
| $680K | 0.03% |
+850,000
| New | +$680K |
|
70
Establishment Labs
ESTA
$1.2B
| $662K | 0.02% |
16,222
-48,078
| -75% | -$1.96M |
|
|
NXTV
71
DELISTED
Simplify Next Intangible Value Index ETF
NXTV
| $659K | 0.02% |
25,825
-1,174
| -4% | -$30K |
|
|
ARR
72
Armour Residential REIT
ARR
$1.77B
| $641K | 0.02% |
37,500
+10,000
| +36% | +$171K |
|
73
CVS Health
CVS
$92.8B
| $617K | 0.02% |
9,105
-9
| -0.1% | -$610 |
|
74
Ultragenyx Pharmaceutical
RARE
$2.89B
| $612K | 0.02% |
16,900
+90
| +0.5% | +$3.26K |
|
75
Cooper Companies
COO
$13.4B
| $583K | 0.02% |
6,908
-8,885
| -56% | -$749K |
|